Doesn't look too bad to be honest.
Revenue is steady.
Cost had dramatically come down.
GP is looking fantastic.
liabilities have also been coming down ($725k drop in this quarter)
Cash is a worry, but hopefully with R&D funds coming in, Nexion should be able to trade their way into a profit. Then if a capital raise is needed, it wont be an issue as share price had gone up due to profitable trading.
Well done Nexion, you are on the right path.
- Forums
- ASX - By Stock
- NNG
- Ann: NNG Quarterly Activities Report and Appendix 4C Jun-23
Ann: NNG Quarterly Activities Report and Appendix 4C Jun-23, page-7
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NNG (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.046M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NNG (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online